Indication
Breast Cancer Related Lymphoedema
2 clinical trials
3 products
Product
LYT-100Product
PlaceboClinical trial
A Phase 2a Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, Pharmacokinetics, and Efficacy of Deupirfenidone (LYT-100) in Patients With Breast Cancer-Related Upper Limb Secondary LymphoedemaStatus: Terminated, Estimated PCD: 2022-09-09
Clinical trial
Does a Regime of Manual Lymphatic Drainage Reduce the Incidence of Breast Cancer-related Lymphoedema Following Axillary Node Clearance: a Randomised Controlled TrialStatus: Completed, Estimated PCD: 2016-01-01